|
May 7
|
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
|
|
May 2
|
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
|
|
Apr 16
|
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
|
|
Mar 19
|
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
|
|
Dec 18
|
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
|
|
Nov 30
|
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
|
|
Nov 28
|
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
|
|
Aug 24
|
Connect Biopharma to Participate in Upcoming September Investor Conferences
|